Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LAHO Holding my shares not for sale. Records will be set my friend.
Strong buy
https://www.barchart.com/stocks/quotes/LAHO
https://www.investing.com/equities/lans-technical
$LAHO
$LAHO..Future of Medicine 36 Stem Centers, 27 Countries..USDHHS conservative estimate $500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO Lans Holdings Successfully Completes Due Diligence of Global~Stem~Cells~Group!!
https://www.otcmarkets.com/stock/LAHO/news
$LAHO GSCG
$LAHO Yale MEDICINE tomorrow
Scientists at the Yale Stem Cell Center believe that understand the most basic mechanisms of stem cell biology will lead to more successful clinical applications. The potential impact of stem cell research on human health is enormous.
https://medicine.yale.edu/stemcell/people/research/therapy.aspx
https://medicine.yale.edu/news/medicineatyale/a-shangrila-for-stem-cell-research-at-yale.aspx
..Alzheimer’s is also known to be influenced by genetics, with certain genetic variants increasing one’s risk of developing the disease. Using the power of stem cells, our scientists have the ability to study an unprecedentedly large number of genetically diverse cells from people with Alzheimer’s, enabling us to examine how genetics influence disease onset and progression as well as identify new risk-related genes.
Alzheimer’s Cure
We are working toward achieving this goal by using stem cells to study the actual human cells affected by the disease and discern its underlying causes.
https://nyscf.org/research-institute/disease-focuses/alzheimers-disease/
Stem cell treatments
Medical researchers believe that stem cell treatments have the potential to change the face of human disease and alleviate suffering.
https://www.sciencedaily.com/terms/stem_cell_treatments.htm
Types of Stem Cell Transplants for Cancer Treatment
https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/types-of-transplants.html
The Global Stem Cells Group
- making the benefits of stem cell medicine a reality for both doctors and patients worldwide.
Through Stem Cell Training, Inc., we provide intensive, hands-on stem cell training to qualified physicians and high level medical professionals worldwide, which includes regenerative medicine fundamentals and the latest cellular medicine protocols. Through our stem cell training programs, physicians are able to provide life-changing medical solutions for patients in their office or clinical setting. Through Stem Cell Training Inc., we share the latest methods, know-how, and technological facilities with medical professionals. We offer courses, seminars, and workshops year round on stem cell therapy and treatments.
Through AdiMarket, we provide an online resource center for biomedical products and equipment needed to conduct stem cell therapies in office or clinic. AdiMarket is staffed by knowledgeable attendants to help each physician fulfill their specific product and equipment needs.
GSCG’s Stem Cell Center is a one-of-a-kind worldwide medical practice network of highly qualified, experienced physicians who provide stem cell solutions within their areas of practice. Stem Cell Center is the largest membership network of regenerative medicine clinics in the world, providing cutting edge care with the latest advancements in cellular therapies to patients worldwide. Stem Cell Center's mission is to make the promise of stem cell medicine become a reality for patients around the world.
Stem Data is a powerful Regenerative medicine Practice Management System designed to be an all-in-one, easy-to-use, intuitive, patient data management software for any healthcare environment.
And finally our Stem Cell laboratory Division offers a turn key state of the art stem cell processing center allowing our clients to conduct research and perform highly advanced stem cell procedures.
http://www.stemcellsgroup.com/our-story/
$LAHO
$LAHO.. world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150088612
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
Harvard
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
$LAHO STEM CELLS FUTURE OF MEDICINE!
$LAHO YALE..Stem cells..jacks of all trades. alleviating..heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
OXFORD
Human cells and tissues for transplantation can save lives or restore essential functions.
a corneal graft can restore sight in corneal blindness;
the transplantatin
https://www.who.int/transplantation/cell_tissue/en/
Oxford
Therapeutic Use of Stem Cells in Treatment of Burn Injuries
There currently does not exist an artificial model of skin that perfectly replicates the architecture and functionality of uninjured skin for transplantation purposes.
...Combination therapy using stem cells and tissue matrices for optimized tissue regeneration provide a possible solution to some of these problems.
https://academic.oup.com/jbcr/article/39/2/175/4796741
https://investorshub.advfn.com/uimage/uploads/2019/7/25/TPQGGVAUVTAMWV.jpg
Harvard Stem Cell
..Our mission is to find cures for human disease
https://hsci.harvard.edu/
Global Stem Cells Group participated as a expositor in the 23rd Congress ISAPS 2016 in Kyoto, Japan
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
..The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells..
http://www.stemcellsgroup.com/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
Global Stem Cells Group Inc Advisory Board
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
$LAHO GLOBAL EXPERTS TRUSTED VALID!
$LAHO GSCG listed Next to Big Players!
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150091805
$LAHO EXPERTS, VENDORS, RESELLERS..WHO IS WHO..HIGH SPIRITS!
$LAHO This is real personalized medicine,..the "Holy Grail.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Death BY prescription
FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Oxford
a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon
https://www.stemcells.ox.ac.uk/home
Harvard Stem Cell
..Our mission is to find cures for human diseases.
https://hsci.harvard.edu/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150088612
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
$LAHO MINIMAL VALUE..CARTEL FDA..STEM CELLS IS THE FUTURE OF MEDICINE.
$LAHO..36 Stem Centers, 27 Countries..Future of Medicine-USDHHS conservative estimate $500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO ‘immortal’ stem cells estimate $500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO Stem Cells FUTURE OF MEDICINE
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO USDHHS Stem Cells conservative estimate $500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO..Future of Medicine 36 Stem Centers, 27 Countries.
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO Biotech has outperformed many times over.
year-to-date gain: 559.9 percent
year-to-date gain: 318.97 percent
year-to-date gain: 245.12 percent
https://investingnews.com/daily/life-science-investing/biotech-investing/top-nasdaq-biotech-stocks/
NASDAQ Biotechnology (NBI) long term $196 today $3300.
upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
In a meltup economy (over valuation) invest in Stem's not trends.
$LAHO
$LAHO Stem cells is the future of medicine. FDA will lose enormous funds and is voicing the concern like a cartel out right denying science, reason and logic.
Death by Prescription
FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human disease
https://hsci.harvard.edu/
Regenerative medicine will dramatically alter the U.S. healthcare industry
.Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
$LAHO
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatment include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
..a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150088612
Blood stem cells produced in vast quantities in the lab
..“The finding is very unexpected and exciting,” says John Dick, a stem-cell biologist at the Prince Margaret Cancer Centre in Toronto, Canada.
If the technique can be applied to humans, it could be used to grow blood stem cells for use in people with blood cancers such as leukaemia whose immune systems have been damaged by chemotherapy.
https://www.nature.com/articles/d41586-019-01690-w
..Cell therapy, as defined by the FDA, is ‘The prevention, treatment, cure or mitigation of disease or injuries in humans by the administration of autologous (derived from same cells), allogeneic or xenogeneic cells that have been manipulated or altered ex vivo’ (1). In autologous stem cell administration, cells are derived from the donor and applied to the donor, while allogeneic stem cell administration involves the transfer of cells from healthy donors to afflicted recipients.
https://www.ddw-online.com/therapeutics/p217261-large-scale-expansion-of-stem-cells-for-therapy-and-screening.html
Researchers Discover Stem Cells Responsible for Growing and Healing Bone
https://news.weill.cornell.edu/news/2018/10/researchers-discover-stem-cells-responsible-for-growing-and-healing-bone
Stanford researchers develop a gel for growing large quantities of neural stem cells
A new gel could help grow the large quantities of neural stem cells needed for sought-after therapies. Its success depends on the cells’ ability to stay in touch.
https://news.stanford.edu/2017/11/02/gel-helps-grow-large-quantities-stem-cells-limited-space/
Exosomes are currently non-reactive and FDA approved.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
$LAHO
Where to find in Vancouver.
https://vancouver.ca/doing-business/cannabis-retail-dealer-business-licence.aspx
Website not sure.
$LAHO Stem Cells Lab..In Progress Japan Kyoto Treatment Center
http://stemcellslab.net/project-plan/
Global Stem Cells Group participated as a expositor in the 23rd Congress ISAPS 2016 in Kyoto, Japan
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
..The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells..
http://www.stemcellsgroup.com/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
Stem cells are daily circulating around the World
In order to find a match, over 40% of the unrelated stem cell transplants involve a donor in a country different from that of the patient, illustrating the unity of humanity beyond national boundaries. Therefore international collaboration is crucial.
International Circulation of Haematopoietic Stem Cells among the six WHO Regions. Unrelated Cord Blood, Bone Marrow and Peripheral Blood Stem Cells. (Source WBMT/WMDA 2009)
https://www.who.int/transplantation/stem_cells/en/
Human Cell and tissue transplantation
Human cells and tissues for transplantation can save lives or restore essential functions.
a corneal graft can restore sight in corneal blindness;
the transplantatin
https://www.who.int/transplantation/cell_tissue/en/
Oxford
Therapeutic Use of Stem Cells in Treatment of Burn Injuries
Burn injuries are one of the most common sources of trauma globally that comprise a significant drain on long-term personal and healthcare cost.
..Human skin accounts for 10% of total body mass, and therefore, burn injuries have significant sequelae on the health and physiology of the entire body. Burn injuries are a major worldwide public health concern.
..There currently does not exist an artificial model of skin that perfectly replicates the architecture and functionality of uninjured skin for transplantation purposes.Full- and split-thickness skin grafts remain most used surgical options for burn injuries but would benefit from improvement on esthetic imperfections of scarring, contracture, and color mismatch.Combination therapy using stem cells and tissue matrices for optimized tissue regeneration provide a possible solution to some of these problems. The idea that allogeneic cell products allow construction of screened cell banks that contain donor stem cells which can be expanded or cryopreserved for tissue regeneration has become more of a reality with the advances in recent research. The possibility of transfecting and further manipulating these cells for individualized transplantation therapy is also not out of reach, highlighting many possible avenues of research in the near future.
https://academic.oup.com/jbcr/article/39/2/175/4796741
..“We are excited to join forces with Lans Holdings,” said Benito Novas, President and CEO of Global Stem Cells Group. “This union will allow us to have access to the capital markets to further fuel our growth as the global stem cells market enters into an accelerated expansion phase
http://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
$LAHO
$LAHO Good to see you here.
SEC TOPIC 12 - Reverse Acquisitions and Reverse Recapitalizations
https://www.sec.gov/corpfin/cf-manual/topic-12
Scientists ..to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
This is real personalized medicine..the "Holy Grail."
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Future Medicine-USDHHS conservative estimate $500 billion
Regenerative medicine will dramatically alter the U.S. healthcare industry
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
..Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
.“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
$LAHO
$LAHO..Future of Medicine 36 Stem Centers, 27 Countries..USDHHS conservative estimate $500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO SEC TOPIC 12 - Reverse Acquisitions and Reverse Recapitalizations
https://www.sec.gov/corpfin/cf-manual/topic-12
Notification of Late Filing
https://www.otcmarkets.com/filing/html?id=12600166&guid=5B-IUK_WErc0jth
Material event's can be noted on the Fins, no?
$LAHO
$LAHO..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
..Global Stem Cells Group, Inc.has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
.“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
$LAHO
$LAHO keynote speaker..Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award..
..“We are excited to have attended the ISAPS conference once more. Our goal, as always, is to promote scientific training for physicians and research in stem cell technology that we hope will contribute to the global discussion on how these therapies can advance human health and longevity” says Benito Novas, founder and CEO.
Mr. Sanguk Ra, Business Director of N-Biotek, a biotechnology added ;”these are very exciting times, we see more and more physicians getting involved in regenerative medicine, and that of course puts more pressure on the scientists to help advance the field”
Both companies, as leaders of the industry, launched their new Turnkey Solution,
http://www.stemcellsgroup.com/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
James awarded Nobel Prize for cancer therapies
..James P. Allison was the first to demonstrate that immunotherapy can treat cancer effectively, initiating an approach that "has provided clinical benefit to many cancer patients" and "stimulated the development of a new class of drugs employing the immune system to fight cancer."
https://www.eurekalert.org/pub_releases/2018-01/bf-ipj013018.php
James. P. Allison, Ph.D., director of the Cancer Research Institute Scientific Advisory Council and co-winner with Tasuku Honjo of the 2018 Nobel Prize in Physiology or Medicine, will receive the Nobel Medal and Diploma from King Carl XVI Gustaf of Sweden at a ceremony in Stockholm.
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
$LAHO 2x Noble BIG STORM INCOMING.
$LAHO ADIMARKET $10M 119 PAGE'S State of the Art Medical Devices!
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
Global Stem Cells Group Inc Advisory Board
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
$LAHO GSCG
$LAHO Removing Cancer Stem Cells’ "Invisibility Cloak"
Jul 18, 2019
..Leukemia stem cells protect themselves against the immune defense by suppressing a target molecule for killer cells. This protective mechanism can be tricked with drugs. In the journal "Nature", scientists from Basel, Tübingen and Heidelberg describe the new therapeutic approaches that can possibly be derived from these results.
..Leukemia stem cells protect themselves against the immune defense by suppressing a target molecule for killer cells. This protective mechanism can be tricked with drugs. In the journal "Nature", scientists from Basel, Tübingen and Heidelberg describe the new therapeutic approaches that can possibly be derived from these results.
.."Our results show how cancer stem cells cleverly trick the immune system. The elucidation of the underlying mechanism now makes it possible to counterattack," says Andreas Trumpp, German Cancer Research Center and HI-STEM.
https://www.technologynetworks.com/cancer-research/news/removing-cancer-stem-cells-invisibility-cloak-321835
Scientists ..to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
This is real personalized medicine..the "Holy Grail."
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Future Medicine-USDHHS conservative estimate $500 billion
Regenerative medicine will dramatically alter the U.S. healthcare industry
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
..Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
$LAHO GSCG
$LAHO UCI..develops noninvasive bone cancer treatment using stem cells
July 18, 2019
..UC Irvine pharmaceutical researchers have developed and tested a new noninvasive treatment that uses engineered stem cells to target and kill bone cancer in mice.
https://www.latimes.com/socal/daily-pilot/news/story/2019-07-18/uci-team-develops-cancer-treatment-using-stem-cells
Jul 22, 2019
MedTech
The first 3D models of Parkinson's, MS are headed into space
..The disease models comprise microglia—the immune cells of the brain—as well as neurons. They are the work of a collaboration between researchers at Aspen Neuroscience in La Jolla, California, the New York Stem Cell Foundation Research Institute and San Diego-based Summit for Stem Cell. The team created them from blood or skin cells taken from Parkinson’s and MS patients, said Aspen's R&D head Andres Bratt-Leal, Ph.D., during a teleconference earlier this month.
https://www.fiercebiotech.com/medtech/first-3d-models-parkinson-s-ms-are-headed-into-space
$LAHO @.02 =28x up, @42x golden
$LAHO GSCG best team to in!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150023566
State of the Art Medical Devices!
119 pages!
http://stemcellslab.net/facility-and-equipment/
Patents and Certs!
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Future Medicine-USDHHS conservative estimate $500 billion
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150000713
$LAHO GSCG The Future Of Medicine!
$LAHO...Allison won..2018 Nobel Prize in Physiology for Medicine jointly with Japanese Tasuku Honjo, MD, PhD.
https://www.facebook.com/globalstemcells/photos/pb.366985720045080.-2207520000.1563555807./2407420589334906/?type=3&theater
https://www.stemcelltraining.net/miami-stem-cells-course-adwords/
This is real personalized medicine..the "Holy Grail."
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Global Stem Cells Group Inc Advisory Board
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
$LAHO GSCG
$LAHO..GSCG..Allison won..2018 Nobel Prize in Physiology for Medicine jointly with Japanese Tasuku Honjo, MD, PhD.
https://www.facebook.com/globalstemcells/photos/pb.366985720045080.-2207520000.1563555807./2407420589334906/?type=3&theater
https://www.stemcelltraining.net/miami-stem-cells-course-adwords/
This is real personalized medicine..the "Holy Grail."
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Global Stem Cells Group Inc Advisory Board
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
$LAHO
$LAHO Scientists ..to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells DD The Holy Grail Stansberry report!
.This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Harvard Stem Cell
..[color=red]Our mission is to find cures for human diseases.[/color]
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
$LAHO
$LAHO Upsurge in venture capital investment..growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
United States Department of Health & Human Services
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149940407
$LAHO
$LAHO Thanks..Stem cells DD The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150000565
$LAHO GSCG
$LAHO Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
(per stansberry report PHD).
https://stansberryresearch.com/articles/the-debt-jubilee-is-getting-mainstream-attention
https://stansberryresearch.com/articles/how-americans-lost-69-of-their-savings-4
Big pharma,and all agencies on their toes. Get in or be left behind when economic reset hits and retirement accounts absorbed when bankers announce 1 month holiday, BYE BYE!
Its my observation that Institution (big ones) will buy in as they all know where Medicine is headed..Stem cells.
$LAHO GSCG
$LAHO..Future Medicine-USDHHS conservative estimate $500 billion
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
$LAHO..Future of Medicine-USDHHS conservative estimate $500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO USDHHS Conservative estimate Stem Cells..500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO Stem Cells DD!!
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO REG-MED..USDHHS conservatively estimated $500 billion by 2020
36 Global Stem Centers in 27 Countries
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://time.com/5394912/stem-cell-treatment/?amp=true
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
$LAHO GSCG RM$$
$LAHO REG..MED..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
$LAHO FANTASTIC$
$LAHO..FEE+cert, Equipment, Expansion + PROFITS..
GSCG ..Florida..fee to attend the course is $3500..
..Is there any special equipment I need in order to incorporate what I have learned into my practice?
In order to incorporate regenerative medicine into your practice after you have completed one of our training courses, you will need several pieces of equipment. You can order them online by visiting www.adimarket.net
..Stem cell treatments under the practice of medicine are allowed, and utilize materials that are produced according to Good Manufacturing Practices (or cGMP) set forth by the FDA. Our procedures do not infringe upon any established regulations in place.
https://www.stemcelltraining.net/faqs/
Cost?
1. 1500 x $3500 = $5Million
3. Expansion x 37 Centers +?
4. Procedures cost average $15k x 2000 patients = $30M.
$LAHO GSCG
$LAHO..GSCG..to Sign Strategic Alliance with BioTrend, Turkey
..“This new alliance with BioTrend is a great opportunity to advance the benefits of stem cell medicine in Turkey,” says Global Stem Cells Group CEO Benito Novas. “Turkey’s geographic location bridges Europe and Asia, allowing GSCG to have a widespread influence in establishing our regenerative medicine presence in both Europe and Asia.
http://www.stemcellsgroup.com/biotrend-alliance/
https://biotrend.com.tr/
$LAHO GSCG